Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cellectis S.A. ADR (NQ: CLLS )

20.64 USD -1.83 (-8.14%)
Official Closing Price Updated: 7:42 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 346,226
Open 21.99
Bid (Size) 19.96 (5)
Ask (Size) 21.55 (1)
Prev. Close 22.47
Today's Range 20.19 - 22.60
52wk Range 7.320 - 34.71
Shares Outstanding 42,406,368
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST
From GlobeNewswire News Releases
Cellectis, Cytovia Therapeutics Ink Gene-Edited Therapy Pact For Oncology Indications
Cytovia Therapeutics IncandCellectis SA(NASDAQ:CLLS) have entered into a strategicresearch and ... 
Tags Biotech Market News Small Cap
From Benzinga

Performance

YTD
-25.22%
-25.22%
1 Month
-31.45%
-31.45%
3 Month
-14.75%
-14.75%
6 Month
+15.11%
+15.11%
1 Year
+23.30%
+23.30%

More News

Read More
Cellectis Announces Launch of Follow-On Offering
From GlobeNewswire News Releases
Cellectis Reaches Analyst Target Price
Tags ETFs
From ETF Channel
7 CRISPR Stocks for the Future of Medicine
Tags NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA,NASDAQ:BEAM,NASDAQ:CLLS,NASDAQ:SGMO,NASDAQ:CLXT CLXT EDIT
From InvestorPlace
Interesting CLLS Put And Call Options For August 2021
Tags Stocks
From Market News Video
Stock Upgrades: Cellectis Shows Rising Relative Strength
From Investor's Business Daily
Thinking about buying stock in Aphria, Drive Shack, Gevo, Cellectis, or Sesen Bio?
From PR Newswire
78 Biggest Movers From Yesterday
Tags CLLS MNKD Movers From Yesterday
From Benzinga
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Tags Offerings NTRA ICCC
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Tags PODD Market News LMAT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]